403 related articles for article (PubMed ID: 27774986)
1. Targeted inhibition of the COP9 signalosome for treatment of cancer.
Schlierf A; Altmann E; Quancard J; Jefferson AB; Assenberg R; Renatus M; Jones M; Hassiepen U; Schaefer M; Kiffe M; Weiss A; Wiesmann C; Sedrani R; Eder J; Martoglio B
Nat Commun; 2016 Oct; 7():13166. PubMed ID: 27774986
[TBL] [Abstract][Full Text] [Related]
2. Adaptive exchange sustains cullin-RING ubiquitin ligase networks and proper licensing of DNA replication.
Zhang Y; Jost M; Pak RA; Lu D; Li J; Lomenick B; Garbis SD; Li CM; Weissman JS; Lipford JR; Deshaies RJ
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2205608119. PubMed ID: 36037385
[TBL] [Abstract][Full Text] [Related]
3. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
[TBL] [Abstract][Full Text] [Related]
4. Immunodepletion and Immunopurification as Approaches for CSN Research.
Golan A; Wei N; Pick E
Methods Mol Biol; 2016; 1449():103-16. PubMed ID: 27613030
[TBL] [Abstract][Full Text] [Related]
5. Azaindoles as Zinc-Binding Small-Molecule Inhibitors of the JAMM Protease CSN5.
Altmann E; Erbel P; Renatus M; Schaefer M; Schlierf A; Druet A; Kieffer L; Sorge M; Pfister K; Hassiepen U; Jones M; Ruedisser S; Ostermeier D; Martoglio B; Jefferson AB; Quancard J
Angew Chem Int Ed Engl; 2017 Jan; 56(5):1294-1297. PubMed ID: 27981705
[TBL] [Abstract][Full Text] [Related]
6. The COP9 signalosome: A versatile regulatory hub of Cullin-RING ligases.
Schulze-Niemand E; Naumann M
Trends Biochem Sci; 2023 Jan; 48(1):82-95. PubMed ID: 36041947
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of Cullin 2 RING E3 ligase regulation by the COP9 signalosome.
Faull SV; Lau AMC; Martens C; Ahdash Z; Hansen K; Yebenes H; Schmidt C; Beuron F; Cronin NB; Morris EP; Politis A
Nat Commun; 2019 Aug; 10(1):3814. PubMed ID: 31444342
[TBL] [Abstract][Full Text] [Related]
8. The COP9 signalosome inhibits Cullin-RING E3 ubiquitin ligases independently of its deneddylase activity.
Suisse A; Békés M; Huang TT; Treisman JE
Fly (Austin); 2018; 12(2):118-126. PubMed ID: 29355077
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the human COP9 signalosome.
Lingaraju GM; Bunker RD; Cavadini S; Hess D; Hassiepen U; Renatus M; Fischer ES; Thomä NH
Nature; 2014 Aug; 512(7513):161-5. PubMed ID: 25043011
[TBL] [Abstract][Full Text] [Related]
10. Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/Jab1.
Echalier A; Pan Y; Birol M; Tavernier N; Pintard L; Hoh F; Ebel C; Galophe N; Claret FX; Dumas C
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1273-8. PubMed ID: 23288897
[TBL] [Abstract][Full Text] [Related]
11. IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5.
Zhang J; Zhao R; Yu C; Bryant CLN; Wu K; Liu Z; Ding Y; Zhao Y; Xue B; Pan ZQ; Li C; Huang L; Fang L
J Proteome Res; 2020 Mar; 19(3):1119-1130. PubMed ID: 31950832
[TBL] [Abstract][Full Text] [Related]
12. Structural and biochemical characterization of the Cop9 signalosome CSN5/CSN6 heterodimer.
Birol M; Enchev RI; Padilla A; Stengel F; Aebersold R; Betzi S; Yang Y; Hoh F; Peter M; Dumas C; Echalier A
PLoS One; 2014; 9(8):e105688. PubMed ID: 25144743
[TBL] [Abstract][Full Text] [Related]
13. Roles of COP9 signalosome in cancer.
Lee MH; Zhao R; Phan L; Yeung SC
Cell Cycle; 2011 Sep; 10(18):3057-66. PubMed ID: 21876386
[TBL] [Abstract][Full Text] [Related]
14. The novel Jab1 inhibitor CSN5i-3 suppresses cell proliferation and induces apoptosis in human breast cancer cells.
Xiao H; Claret FX; Shen Q
Neoplasma; 2019 May; 66(3):481-486. PubMed ID: 30868895
[TBL] [Abstract][Full Text] [Related]
15. The Arabidopsis COP9 signalosome is essential for G2 phase progression and genomic stability.
Dohmann EM; Levesque MP; De Veylder L; Reichardt I; Jürgens G; Schmid M; Schwechheimer C
Development; 2008 Jun; 135(11):2013-22. PubMed ID: 18434413
[TBL] [Abstract][Full Text] [Related]
16. The β-catenin E3 ubiquitin ligase SIAH-1 is regulated by CSN5/JAB1 in CRC cells.
Jumpertz S; Hennes T; Asare Y; Vervoorts J; Bernhagen J; Schütz AK
Cell Signal; 2014 Sep; 26(9):2051-9. PubMed ID: 24882689
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo.
Asare Y; Ommer M; Azombo FA; Alampour-Rajabi S; Sternkopf M; Sanati M; Gijbels MJ; Schmitz C; Sinitski D; Tilstam PV; Lue H; Gessner A; Lange D; Schmid JA; Weber C; Dichgans M; Jankowski J; Pardi R; de Winther MP; Noels H; Bernhagen J
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2766-E2775. PubMed ID: 28292897
[TBL] [Abstract][Full Text] [Related]
18. The COP9 signalosome counteracts the accumulation of cullin SCF ubiquitin E3 RING ligases during fungal development.
von Zeska Kress MR; Harting R; Bayram Ö; Christmann M; Irmer H; Valerius O; Schinke J; Goldman GH; Braus GH
Mol Microbiol; 2012 Mar; 83(6):1162-77. PubMed ID: 22329854
[TBL] [Abstract][Full Text] [Related]
19. The C-terminal tail of CSNAP attenuates the CSN complex.
Füzesi-Levi MG; Ben-Nissan G; Listov D; Fridmann Sirkis Y; Hayouka Z; Fleishman S; Sharon M
Life Sci Alliance; 2023 Oct; 6(10):. PubMed ID: 37460146
[TBL] [Abstract][Full Text] [Related]
20. Protection of cullin-RING E3 ligases by CSN-UBP12.
Wu JT; Chan YR; Chien CT
Trends Cell Biol; 2006 Jul; 16(7):362-9. PubMed ID: 16762551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
